Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Friday's Intraday Session

 

Gainers

  • Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume of 9.3 million, which is 1477.4% of its average full-day volume over the last 100 days. The company's market cap stands at $18.0 million.
  • Exicure (NASDAQ:XCUR) shares rose 21.72% to $0.25. Trading volume for this security as of 13:31 EST is 50.6 million, which is 399.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $31.2 million.
  • Lyra Therapeutics (NASDAQ:LYRA) shares moved upwards by 16.31% to $5.03. Trading volume for Lyra Therapeutics's stock is 4.7 million as of 13:31 EST. This is 17197.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $65.3 million.
  • Bicycle Therapeutics (NASDAQ:BCYC) shares rose 16.27% to $43.87. Bicycle Therapeutics's stock is trading at a volume of 808.0K shares as of 13:31 EST. This is 335.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.2 billion.
  • Nurix Therapeutics (NASDAQ:NRIX) shares moved upwards by 13.8% to $15.09. As of 13:31 EST, Nurix Therapeutics's stock is trading at a volume of 315.9K, which is 70.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $676.8 million. As per the press release, Q1 earnings came out yesterday.
  • Ikena Oncology (NASDAQ:IKNA) stock increased by 13.62% to $7.96. Ikena Oncology's stock is trading at a volume of 93.2K shares as of 13:31 EST. This is 70.5% of its average full-day volume over the last 100 days. The company's market cap stands at $287.6 million.

Losers

  • Kaleido Biosciences (NASDAQ:KLDO) shares decreased by 69.9% to $0.45 during Friday's regular session. Trading volume for this security as of 13:31 EST is 8.1 million, which is 8174.5% of its average full-day volume over the last 100 days. The company's market cap stands at $18.9 million.
  • Genocea Biosciences (NASDAQ:GNCA) stock decreased by 51.71% to $0.63. Genocea Biosciences's stock is trading at a volume of 1.0 million shares as of 13:31 EST. This is 642.2% of its average full-day volume over the last 100 days. The company's market cap stands at $36.8 million.
  • C4 Therapeutics (NASDAQ:CCCC) stock decreased by 48.83% to $11.72. The current volume of 590.5K shares is 105.5% of C4 Therapeutics's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $571.2 million.
  • Rubius Therapeutics (NASDAQ:RUBY) stock declined by 41.86% to $3.41. As of 13:31 EST, Rubius Therapeutics's stock is trading at a volume of 2.6 million, which is 341.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $307.2 million.
  • BioCryst Pharmaceuticals (NASDAQ:BCRX) stock decreased by 37.39% to $11.2. Trading volume for this security as of 13:31 EST is 27.0 million, which is 669.2% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 billion.
  • Nutex Health (NASDAQ:NUTX) shares decreased by 25.05% to $9.28. Trading volume for Nutex Health's stock is 972.4K as of 13:31 EST. This is 113.8% of its average full-day volume over the last 100 days. The company's market cap stands at $5.9 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.